GR3031169T3 - Cd8 binding domain peptides. - Google Patents

Cd8 binding domain peptides.

Info

Publication number
GR3031169T3
GR3031169T3 GR990402262T GR990402262T GR3031169T3 GR 3031169 T3 GR3031169 T3 GR 3031169T3 GR 990402262 T GR990402262 T GR 990402262T GR 990402262 T GR990402262 T GR 990402262T GR 3031169 T3 GR3031169 T3 GR 3031169T3
Authority
GR
Greece
Prior art keywords
ctl
binding domain
peptides
seq
peptide
Prior art date
Application number
GR990402262T
Other languages
English (en)
Inventor
Carol Clayberger
Alan M Krensky
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of GR3031169T3 publication Critical patent/GR3031169T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR990402262T 1991-11-08 1999-09-08 Cd8 binding domain peptides. GR3031169T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79192591A 1991-11-08 1991-11-08
PCT/US1992/009440 WO1993008817A1 (en) 1991-11-08 1992-11-03 Cd8 binding domain peptides

Publications (1)

Publication Number Publication Date
GR3031169T3 true GR3031169T3 (en) 1999-12-31

Family

ID=25155235

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402262T GR3031169T3 (en) 1991-11-08 1999-09-08 Cd8 binding domain peptides.

Country Status (11)

Country Link
US (1) US5620956A (el)
EP (1) EP0661985B1 (el)
JP (1) JP3345419B2 (el)
AT (1) ATE181836T1 (el)
AU (1) AU673985B2 (el)
CA (1) CA2122266A1 (el)
DE (1) DE69229562T2 (el)
DK (1) DK0661985T3 (el)
ES (1) ES2136094T3 (el)
GR (1) GR3031169T3 (el)
WO (1) WO1993008817A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6908094A (en) * 1993-05-05 1994-11-21 Mark L. Tykocinski Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule
US6162434A (en) 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US6103239A (en) * 1996-08-09 2000-08-15 Cel-Sci Corporation Modified HGP-30 heteroconjugates, compositions and methods of use
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
CN1216900C (zh) 1997-04-11 2005-08-31 桑斯塔特医学有限公司 用于调节免疫系统活性和抑制炎症的细胞调节性亲脂肽
CA2474056A1 (en) 2002-01-24 2003-07-31 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
KR101239051B1 (ko) 2005-10-21 2013-03-04 추가이 세이야쿠 가부시키가이샤 심장질환 치료제
AR057582A1 (es) * 2005-11-15 2007-12-05 Nat Hospital Organization Agentes para suprimir la induccion de linfocitos t citotoxicos
CA2648644C (en) 2006-04-07 2016-01-05 Osaka University Muscle regeneration promoter
GB0609121D0 (en) * 2006-05-09 2006-06-21 Univ Birmingham Peptide Therapy
CN101646459B (zh) 2007-01-23 2014-02-12 国立大学法人信州大学 慢性排斥反应抑制剂
ES2425486T3 (es) * 2007-05-09 2013-10-15 Circassia Limited Análisis de pronóstico para determinar la respuesta de células T a antígenos HLA y uso del mismo en el campo del trasplante de tejidos
WO2009148148A1 (ja) 2008-06-05 2009-12-10 国立がんセンター総長が代表する日本国 神経浸潤抑制剤
US8340782B2 (en) 2009-07-08 2012-12-25 Boston Scientific Neuromodulation Corporation Systems and methods of making and using support elements for elongated members of implantable electric stimulation systems
HRP20221490T1 (hr) 2010-05-28 2023-02-03 Chugai Seiyaku Kabushiki Kaisha Poboljšanje antitumorskog odgovora t stanice
MX371187B (es) * 2013-12-06 2020-01-22 Dana Farber Cancer Inst Inc Péptidos terapéuticos.
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
KR20200074160A (ko) 2017-10-20 2020-06-24 가꼬우호우징 효고 이카다이가쿠 항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물
WO2020250940A1 (ja) * 2019-06-11 2020-12-17 小野薬品工業株式会社 免疫抑制剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619458B2 (en) * 1987-01-30 1992-01-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte inhibition by hla peptides

Also Published As

Publication number Publication date
ES2136094T3 (es) 1999-11-16
EP0661985B1 (en) 1999-07-07
DK0661985T3 (da) 2000-01-31
ATE181836T1 (de) 1999-07-15
WO1993008817A1 (en) 1993-05-13
AU3062892A (en) 1993-06-07
EP0661985A1 (en) 1995-07-12
AU673985B2 (en) 1996-12-05
DE69229562T2 (de) 1999-11-25
US5620956A (en) 1997-04-15
EP0661985A4 (en) 1996-07-03
JP3345419B2 (ja) 2002-11-18
JPH07505609A (ja) 1995-06-22
DE69229562D1 (de) 1999-08-12
CA2122266A1 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
GR3031169T3 (en) Cd8 binding domain peptides.
HUP0102900A2 (hu) Javított szilárd fázisú peptidszintézis és a szintézisben alkalmazható anyagok
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
AU9315398A (en) Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
AU1179795A (en) Improved immunogenic compositions against human gastrin 17
Williamson et al. Differential effects of β-endorphin fragments on human natural killing
DE69434137D1 (en) Chaperonin 10
IL105347A0 (en) Multiple sclerosis t-cell receptor
EP0751148A3 (en) D-amino acid substitution analogues of magainin peptides
WO1992017025A3 (en) GnRH analogs
KR940005798A (ko) 지방세포화 억제 인자 유도체, 그의 제조방법 및 용도
DE69120776T2 (de) Neue inhibitorische Peptide
EP0258203A3 (en) Novel substrate peptides
ES8801308A1 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica